COMMON STOCK SUBSCRIPTION AGREEMENTCommon Stock Subscription Agreement • March 11th, 2024 • CancerVAX, Inc. • Pharmaceutical preparations • Nevada
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
INDEPENDENT CONTRACTOR AGREEMENTIndependent Contractor Agreement • March 11th, 2024 • CancerVAX, Inc. • Pharmaceutical preparations • Nevada
This INDEPENDENT CONTRACTOR AGREEMENT (the “Agreement”) is by and between Carla Miller, an individual (the “Contractor”), and CancerVAX, Inc., a Nevada corporation (the “Company”), effective the 1st day of April 2021, the date the Services (as defined below) were first provided by Contractor (the “Effective Date).
SUBSCRIPTION AGREEMENT Offering Series B Preferred Shares in CANCERVAX, INC. Second Floor Santa Barbara, California 93101 $5,000,000 Offering Maximum $100,000 Minimum Investment Amount No Minimum Raise AmountPrivate Placement Subscription Agreement • March 11th, 2024 • CancerVAX, Inc. • Pharmaceutical preparations • Nevada
THIS SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is made this 13th day of October, 2023 by and between CancerVAX, Inc., a Nevada corporation (hereinafter the “Issuer” or “Company”), and the undersigned subscriber (the “Subscriber”), who, for and in consideration of the mutual promises and covenants set forth herein, do hereto agree as follows:
